Key result
PK Papyrus covered stents successfully excluded coronary artery aneurysms in 3 pediatric patients, but 2 patients required subsequent intervention for in-stent restenosis.
Why the study?
Kawasaki disease can cause coronary artery inflammation and aneurysm formation leading to early obstructive disease.
Does the PK Papyrus covered stent effectively exclude coronary artery aneurysms and relieve stenoses in pediatric patients with Kawasaki disease?
Case Report (n=3)
Does the PK Papyrus covered stent effectively exclude coronary artery aneurysms and relieve stenoses in pediatric patients with Kawasaki disease?
The PK Papyrus covered stent can successfully exclude giant coronary artery aneurysms in pediatric Kawasaki disease patients, though in-stent restenosis requiring repeat intervention is a significant short-term limitation.
Answers are grounded in this paper and cite their sources.
Covered stents may exclude pediatric KD aneurysms with ISR at 1 year; leaves open durability and safety in larger cohorts.
Kawasaki disease (KD) is an acute vasculitis that can cause coronary artery inflammation and aneurysm formation leading to early obstructive disease. We describe the use of PK Papyrus covered stents (Biotronic, Inc.) in three pediatric patients to exclude coronary artery aneurysms (CAA) from the circulation and relieve aneurysm associated stenoses. Follow-up angiography at 11-17 months postprocedure demonstrated persistent exclusion of CAA and varying degrees of in-stent restenosis (ISR). Two patients required percutaneous coronary intervention with drug eluting stent (DES) implantation to relieve in-stent stenosis. Our findings suggest that CAA exclusion with the PK Papyrus stent is possible and may be a valuable tool in simultaneously treating stenotic and thrombogenic CAA in pediatric KD patients. ISR of these non-DES remains an issue and may require additional interventions within the short-term to maintain vessel patency.
No takes yet. Share an insight, caveat, or question.
Naimi et al. (2022) conducted a case report in Kawasaki disease-associated giant coronary artery aneurysms (n=3). PK Papyrus covered stents was evaluated on Persistent exclusion of coronary artery aneurysms and in-stent restenosis. PK Papyrus covered stents successfully excluded coronary artery aneurysms in 3 pediatric patients, but 2 patients required subsequent intervention for in-stent restenosis.
Synapse has enriched 10 related papers. Consider them for comparative context: